Retour
72
39
53
Fourchette du Jour
260,61 €
266,74 €
Fourchette 52 Semaines
239,51 €
350,00 €
Volume
1 319 764
Moyenne 50J / 200J
277,87 €
/
287,97 €
Clôture Précédente
261,49 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 11,9 | 0,4 |
| P/B | 1,7 | 2,9 |
| ROE % | 14,4 | 3,9 |
| Net Margin % | 2,2 | 3,8 |
| Rev Growth 5Y % | 12,1 | 10,0 |
| D/E | 0,8 | 0,2 |
Objectif de Cours des Analystes
Hold
325,83 €
+22.6%
Low: 300,00 €
High: 375,00 €
P/E Prévisionnel
8,6
BPA Prévisionnel
30,32 €
Croissance BPA (est.)
+0,0%
CA Est.
280 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
45,90 €
43,96 € – 48,40 €
|
390 B | 5 |
| FY2029 |
41,01 €
39,27 € – 43,24 €
|
350 B | 2 |
| FY2028 |
37,09 €
32,04 € – 41,58 €
|
320 B | 7 |
Points Clés
Revenue grew 12,11% annually over 5 years — strong growth
Earnings grew 73,47% over the past year
ROE of 14,40% — decent returns on equity
Generating 8,39B in free cash flow
P/E of 11,92 — trading at a low valuation
PEG of 0,15 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
12,11%
Revenue (1Y)11,26%
Earnings (1Y)73,47%
FCF Growth (3Y)-9,49%
Qualité
Return on Equity
14,40%
ROIC9,36%
Net Margin2,17%
Op. Margin3,32%
Sécurité
Debt / Equity
0,75
Current Ratio0,85
Interest Coverage6,61
Valorisation
P/E Ratio
11,92
P/B Ratio1,70
EV/EBITDA10,39
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,26% | Revenue Growth (3Y) | 18,66% |
| Earnings Growth (1Y) | 73,47% | Earnings Growth (3Y) | 7,40% |
| Revenue Growth (5Y) | 12,11% | Earnings Growth (5Y) | 2,63% |
| Profitability | |||
| Revenue (TTM) | 274,95B | Net Income (TTM) | 5,96B |
| ROE | 14,40% | ROA | 3,77% |
| Gross Margin | 9,45% | Operating Margin | 3,32% |
| Net Margin | 2,17% | Free Cash Flow (TTM) | 8,39B |
| ROIC | 9,36% | FCF Growth (3Y) | -9,49% |
| Safety | |||
| Debt / Equity | 0,75 | Current Ratio | 0,85 |
| Interest Coverage | 6,61 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 11,92 | P/B Ratio | 1,70 |
| P/S Ratio | 0,26 | PEG Ratio | 0,15 |
| EV/EBITDA | 10,39 | Dividend Yield | 0,02% |
| Market Cap | 71,02B | Enterprise Value | 94,81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 274,95B | 247,12B | 195,27B | 180,52B | 174,07B |
| Net Income | 5,96B | 3,43B | 5,16B | 6,70B | 5,37B |
| EPS (Diluted) | 22,17 | 12,12 | 17,39 | 21,41 | 15,75 |
| Gross Profit | 25,99B | 25,96B | 25,18B | 23,50B | 22,95B |
| Operating Income | 9,13B | 9,42B | 8,54B | 8,45B | 7,94B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 157,92B | 155,88B | 152,76B | 143,89B | 154,89B |
| Total Liabilities | 116,05B | 114,64B | 106,41B | 98,98B | 107,71B |
| Shareholders' Equity | 41,71B | 41,03B | 46,22B | 44,87B | 47,11B |
| Total Debt | 31,46B | 31,97B | 30,93B | 31,55B | 34,27B |
| Cash & Equivalents | 7,68B | 7,55B | 7,82B | 5,92B | 5,08B |
| Current Assets | 47,81B | 48,87B | 37,35B | 30,12B | 36,13B |
| Current Liabilities | 56,34B | 57,98B | 48,72B | 41,23B | 43,57B |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#92 of 1052
#273 of 618
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#152 of 332
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026